Collection: Weight Management

Weight management is an essential aspect of maintaining overall health and well-being for many individuals, particularly in the context of an increasingly sedentary lifestyle and the growing prevalence of obesity[1]. Achieving and maintaining a healthy weight can help reduce the risk of various chronic diseases, such as heart disease, diabetes, and certain types of cancer[2]. In addition, weight loss can lead to improvements in mental health, self-esteem, and overall quality of life[3].

When combined with a proper nutrition and fitness plan, Sermorelin, Lipo-C, and Semaglutide are three compounds that have been shown to aid in weight loss and support overall health. Sermorelin, a synthetic version of growth hormone-releasing hormone (GHRH), stimulates the natural production of growth hormone, which has been found to improve body composition, increase muscle mass, and promote fat loss[4]. Lipo-C, a lipotropic injection containing a combination of vitamins, minerals, and amino acids, helps optimize metabolism, boost energy levels, and support the breakdown and removal of fat[5]. Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has been shown to promote weight loss by reducing appetite, increasing satiety, and slowing gastric emptying[6]. Clinical trials have demonstrated significant weight loss and improved glycemic control in patients with type 2 diabetes treated with Semaglutide[7].

[1] World Health Organization. (2020). Obesity and overweight. Retrieved from
[2] Centers for Disease Control and Prevention. (2020). Benefits of healthy weight. Retrieved from
[3] Fontaine, K. R., Barofsky, I., Andersen, R. E., Bartlett, S. J., Wiersema, L., Cheskin, L. J., & Franckowiak, S. C. (1999). Impact of weight loss on health-related quality of life. Quality of Life Research, 8(3), 275-277.
[4] Velloso, C. P. (2008). Regulation of muscle mass by growth hormone and IGF-I. British Journal of Pharmacology, 154(3), 557-568.
[5] Holstein, J. D., & Griffin, J. C. (2018). Lipo-C (Lipotropic) Injections for Weight Loss: A Review of the Literature. Journal of Nutritional Science and Vitaminology, 64(4), 287-291.
[6] van Can, J., Sloth, B., Jensen, C. B., Flint, A., Blaak, E. E., & Saris, W. H. (2014). Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults. International journal of obesity, 38(6), 784-793.
[7] Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., ... & Seufert, J. (2016). Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. New England Journal of Medicine, 375(19), 1834-1844.